Hinova Pharma Funding: $219M Raised, Series C (2020)

Hinova Pharma funding overview

Hinova Pharma is based in Chengdu, China. Hinova Pharma has raised $219M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in October 2020. The round record for Hinova Pharma runs through 2020; nothing later has been disclosed. Investors on record include Shenzhen Investment Holdings, Hangzhou Tigermed, Sinopharm Group, DNV Capital, Huarong Rongde, Infinity Group and 1 others. 7 distinct backers are named across the disclosed rounds.

Hinova Pharma at a glance

Total raised: $219M
Latest round: Series C
Latest round date: October 2020
Headquarters: Chengdu, China
Notable investors: Shenzhen Investment Holdings, Hangzhou Tigermed, Sinopharm Group, DNV Capital, Huarong Rongde, Infinity Group, Tigermed

Frequently asked about Hinova Pharma funding

How much has Hinova Pharma raised?: Hinova Pharma has raised $219M in total disclosed funding across the rounds on record.
Who has invested in Hinova Pharma?: Shenzhen Investment Holdings, Hangzhou Tigermed, Sinopharm Group, DNV Capital, Huarong Rongde, Infinity Group are named among the investors backing Hinova Pharma.
What was the latest Hinova Pharma funding round?: The most recent disclosed round is a Series C, announced in October 2020.
Where is Hinova Pharma based?: Hinova Pharma is based in Chengdu, China.
When did Hinova Pharma last raise?: The last disclosed Hinova Pharma round closed in October 2020 at Series C.

Hinova Pharma totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Chengdu below to benchmark round size and investor mix.

Hinova Pharma Funding: $219M Raised, Series C (2020)

Hinova Pharma funding overview

Hinova Pharma at a glance

Frequently asked about Hinova Pharma funding

Companies related to Hinova Pharma (23)

Browse related funding lists (3)